Nuvaira Competitors and Similar CompaniesClear all
Nuvaira's competitors and similar companies include Pulmonx, TFF Pharmaceuticals, Lung Therapeutics and Cerebral Therapeutics.
 Pulmonx Pulmonx is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema. |  TFF Pharmaceuticals TFF Pharmaceuticals is a biopharmaceutical company focused on developing drug products based on the Thin Film Freezing (TFF) technology platform. |  Lung Therapeutics Lung Therapeutics is a biopharmaceutical company developing medicines for unmet medical needs in fibrosis and lung disease. |  Cerebral Therapeutics Cerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients with uncontrolled neurological diseases. | ||
Founding Date | Founding Date 2008 | Founding Date 1998 | Founding Date 2018 | Founding Date 2013 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Plymouth, US HQ Maple Grove, US | Locations Redwood City, US HQ Neuchâtel, CH | Locations Austin, US HQ | Locations Austin, US HQ | Locations Aurora, US HQ Oakdale, US |
Employees | Employees 2212% decrease | Employees 2209% increase | Employees 1927% increase | Employees 10 | Employees 2 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 265.1 m | Valuation ($) 8.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $90.5m (FY, 2025) | Revenue (est.) $733.9k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($54m) (FY, 2025) | Net income ($21.2m) (FY, 2023) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 79m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 36m (about 7 years ago) | Latest funding round $ 7.8m (about 7 years ago) |
Total funding raised | Total funding raised $ 147.6m | Total funding raised $ 257.4m | Total funding raised $ 22.3m | Total funding raised $ 53.9m | Total funding raised $ 10.8m |
For sources of this data, please see the company profile
View Company Profiles
Pulmonx
HQ
Redwood City, US
Employees
220↑ 9% increase
Pulmonx is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema.
View companyTFF Pharmaceuticals
HQ
Austin, US
Employees
19↑ 27% increase
TFF Pharmaceuticals is a biopharmaceutical company focused on developing drug products based on the Thin Film Freezing (TFF) technology platform.
View companyLung Therapeutics
HQ
Austin, US
Employees
10
Lung Therapeutics is a biopharmaceutical company developing medicines for unmet medical needs in fibrosis and lung disease.
View companyCerebral Therapeutics
HQ
Aurora, US
Employees
2
Cerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients with uncontrolled neurological diseases.
View company